Intuitive Surgical, Inc. (NASDAQ:ISRG) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Key Points

• Intuitive Surgical, Inc. has received a consensus recommendation of "Moderate Buy" from analysts, with fourteen buy ratings, seven hold ratings, and one sell rating.
• The average twelve-month price target among analysts is $594.19, reflecting positive sentiment towards the company's future performance.
• In recent transactions, insiders sold significant shares, with one EVP reducing their position by 92.73%, indicating potential concerns or profit-taking among executives.

Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the twenty-two ratings firms that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and fourteen have issued a buy rating on the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $594.1905.

Several research firms have commented on ISRG. Deutsche Bank Aktiengesellschaft reissued a "sell" rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. BTIG Research reissued a "buy" rating and set a $571.00 target price on shares of Intuitive Surgical in a research report on Wednesday. UBS Group lifted their target price on shares of Intuitive Surgical from $547.00 to $585.00 and gave the stock a "neutral" rating in a research report on Wednesday, July 23rd. Wells Fargo & Company lifted their price target on shares of Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a report on Wednesday, July 23rd. Finally, Evercore ISI lifted their price target on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a report on Tuesday, July 8th.

Insider Buying and Selling

In related news, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the sale, the executive vice president owned 353 shares of the company's stock, valued at approximately $173,845.44. The trade was a 92.73% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the sale, the insider directly owned 19,827 shares in the company, valued at $9,368,059.23. This trade represents a 59.69% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 45,224 shares of company stock valued at $21,716,492. 0.70% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the business. Vanguard Group Inc. grew its stake in Intuitive Surgical by 2.1% in the 2nd quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider's stock valued at $18,115,025,000 after buying an additional 670,302 shares in the last quarter. State Street Corp grew its stake in Intuitive Surgical by 1.2% in the 2nd quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider's stock valued at $8,451,223,000 after buying an additional 182,871 shares in the last quarter. Geode Capital Management LLC grew its stake in Intuitive Surgical by 1.4% in the 2nd quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider's stock valued at $4,429,590,000 after buying an additional 109,904 shares in the last quarter. Norges Bank purchased a new position in Intuitive Surgical in the 2nd quarter valued at approximately $2,569,260,000. Finally, Invesco Ltd. grew its stake in Intuitive Surgical by 4.8% in the 2nd quarter. Invesco Ltd. now owns 4,421,133 shares of the medical equipment provider's stock valued at $2,402,488,000 after buying an additional 201,159 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Up 2.1%

Intuitive Surgical stock opened at $452.35 on Friday. Intuitive Surgical has a 52 week low of $425.00 and a 52 week high of $616.00. The company's 50 day moving average price is $463.55 and its two-hundred day moving average price is $500.00. The stock has a market cap of $162.16 billion, a P/E ratio of 63.09, a P/E/G ratio of 4.64 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm had revenue of $2.44 billion for the quarter, compared to analysts' expectations of $2.35 billion. During the same quarter last year, the firm earned $1.78 EPS. The company's quarterly revenue was up 21.4% compared to the same quarter last year. On average, equities analysts anticipate that Intuitive Surgical will post 6.43 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.